CD4 and tuberculosis: A viral-vectored TBV candidate, ChAd63/MVA Pfs25-IMX313, did not appear to induce strong antibody responses in humans, and this was associated with an inability to elicit CD4+ T cell responses, resulting in weak TB efficacy (33, 34).